Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

26. April 2018 08:00 ET | Quelle: Insys Therapeutics, Inc.

INSYS Therapeutics and University of California (UC) San Diego Center for Medicinal Cannabis Research to Collaborate on Clinical Trial

PHOENIX, April 26, 2018 (GLOBE NEWSWIRE) -- NSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology,...
25. April 2018 06:00 ET | Quelle: Insys Therapeutics, Inc.

INSYS Therapeutics to Report First Quarter 2018 Results on May 8

PHOENIX, April 25, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray...
18. April 2018 08:30 ET | Quelle: Insys Therapeutics, Inc.

INSYS Therapeutics to Advance Clinical Research of Dronabinol Inhalation Using Novel Breath-Actuated Device

PHOENIX, April 18, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray...
02. April 2018 08:30 ET | Quelle: Insys Therapeutics, Inc.

INSYS Therapeutics Appoints Trudy Vanhove to Board of Directors

PHOENIX, April 02, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray...
19. März 2018 08:00 ET | Quelle: Insys Therapeutics, Inc.

INSYS Therapeutics Reiterates Commitment to Compliant and Ethical Business Practices and Advancing Innovative Product Pipeline

PHOENIX, March 19, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray...
08. März 2018 16:15 ET | Quelle: Insys Therapeutics, Inc.

INSYS Therapeutics Reports Fourth Quarter and Full Year 2017 Results

PHOENIX, March 08, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray...
02. März 2018 08:30 ET | Quelle: Insys Therapeutics, Inc.

INSYS Therapeutics Initiates Phase 3 Clinical Trial of Cannabidiol (CBD) Oral Solution for Treatment of Infantile Spasms

PHOENIX, March 02, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray...
01. März 2018 09:00 ET | Quelle: Insys Therapeutics, Inc.

INSYS Therapeutics Confirms Completion of Founder’s Independent Trust

PHOENIX, March 01, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray...
23. Februar 2018 09:00 ET | Quelle: Insys Therapeutics, Inc.

INSYS Therapeutics to Report Fourth Quarter 2017 Results on March 8

PHOENIX, Feb. 23, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology,...
20. Februar 2018 09:13 ET | Quelle: Insys Therapeutics, Inc.

INSYS Therapeutics to Present at RBC Healthcare Conference

PHOENIX, Feb. 20, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology,...

Vorherige Seite

Nächste Seite